ALPP-targeted engineered T-cell therapy
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for ALPP-targeted engineered T-cell therapy, covering 2026-01-22 to 2026-01-28. Get the full timeline:
Most recent: Clinical Trial Update: Engineered T-Cell Therapy for Patients With ALPP-Positive Advanced Solid Tumors [EARLY_Phase 1]